Search
Search Results
-
Evaluation of ivabradine plus beta-blocker versus beta-blocker alone in addition to standard care in reducing hospitalization and major adverse cardiovascular event in patients with chronic heart failure: a prospective observational study in tertiary care hospital in central India
BackgroundIn recent years, there has been an increase in cases of heart failure, ultimately leading to an increase in hospitalization for heart...
-
Beta-blocker efficacy for intra- and interdialytic hypertension patients: a systematic review and meta-analysis
PurposeIntradialytic hypertension affects 5–15% of hemodialysis patients, yet relevant studies are relatively scarce. It is also associated with...
-
Effect of Beta-Blocker on Long-Term Major Cardiovascular Events in High Atherosclerotic Risk Population
PurposeBeta-blocker is a frequently used medication in cardiovascular diseases. However, long-term benefit of beta-blocker in patients with preserved...
-
Evaluation of beta-blocker effects on patients with traumatic brain injury: interventional double-blinded randomized controlled trial
BackgroundTraumatic brain injury (TBI) is a major cause of death and disability throughout the world. Traumatic injury is one of the most common...
-
The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line
PurposeVascular endothelial growth factor (VEGF) inhibition is one of the cornerstones of treatment in the treatment of metastatic renal cell...
-
Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study
BackgroundBeta-blocker (BB) and calcium channel blocker (CCB) antihypertensive drugs are commonly used in pregnancy. However, data on their relative...
-
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation
The prevailing treatment stratagem in cancer therapy still challenges the dilemma of a probable metastatic spread following an initial diagnosis....
-
A nationwide analysis on the interaction between frailty and beta-blocker therapy in hip fracture patients
IntroductionHip fracture patients, who are often frail, continue to be a challenge for healthcare systems with a high postoperative mortality rate....
-
Cardiovascular and Adverse Effects of Glucagon for the Management of Suspected Beta Blocker Toxicity: a Case Series
BackgroundAlthough glucagon use in beta blocker toxicity has been recommended for many years, evidence for its safety and efficacy in humans is...
-
Influence of a chronic beta-blocker therapy on perioperative opioid consumption – a post hoc secondary analysis
BackgroundBeta-blocker (BB) therapy plays a central role in the treatment of cardiovascular diseases. An increasing number of patients with...
-
ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis
Anthracyclines and trastuzumab are widely used to treat breast cancer but increase the risk of cardiomyopathy and heart failure. With the use of...
-
Preoperative beta-blocker in ventricular dysfunction patients: need a more granular quality metric
BackgroundThe use of preoperative beta-blockers has been accepted as a quality standard for patients undergoing coronary artery bypass graft (CABG)...
-
Beta-blocker use and breast cancer outcomes: a meta-analysis
PurposeBeta blockers (BBs) are commonly used cardiovascular medications, and their association with breast cancer outcomes has been examined in...
-
Nonselective beta-adrenoceptor blocker use and risk of Parkinson’s disease: from multiple real-world evidence
BackgroundPeople with hypertension have a higher risk of develo** Parkinson’s disease (PD), epidemiological evidence suggests that multiple...
-
The role of beta-blocker drugs in critically ill patients: a SIAARTI expert consensus statement
BackgroundThe role of β-blockers in the critically ill has been studied, and data on the protective effects of these drugs on critically ill patients...
-
Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias
The study investigates the prognostic significance of beta-blocker (BB) dose in patients with ventricular tachyarrhythmias. Limited data regarding...
-
EvaLuation of early CRRT and beta-blocker InTervention in patients with ECMO (ELITE) trial: study protocol for a 2 × 2 partial factorial randomized controlled trial
BackgroundIn critically ill patients requiring extracorporeal membrane oxygenation (ECMO) therapy, early initiation of continuous renal replacement...
-
Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?
Purpose of ReviewControversy exists whether beta-blockers should be given before primary percutaneous coronary intervention (PCI) or to defer their...